A detailed history of Highline Wealth Partners LLC transactions in Dexcom Inc stock. As of the latest transaction made, Highline Wealth Partners LLC holds 9 shares of DXCM stock, worth $648. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9
Holding current value
$648
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$64.0 - $116.06 $576 - $1,044
9 New
9 $603,000
Q2 2024

Oct 28, 2024

BUY
$110.31 - $140.45 $772 - $983
7 Added 77.78%
16 $1.81 Million
Q1 2024

Oct 28, 2024

BUY
$114.22 - $140.1 $571 - $700
5 Added 55.56%
14 $1.94 Million
Q2 2023

Oct 29, 2024

BUY
$112.47 - $130.98 $562 - $654
5 Added 55.56%
14 $1.8 Million
Q1 2023

Oct 28, 2024

BUY
$104.0 - $122.92 $520 - $614
5 Added 55.56%
14 $1.63 Million
Q4 2022

Oct 29, 2024

BUY
$84.98 - $122.67 $424 - $613
5 Added 55.56%
14 $1.59 Million
Q3 2022

Oct 29, 2024

BUY
$76.35 - $94.18 $381 - $470
5 Added 55.56%
14 $1.13 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $27.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Highline Wealth Partners LLC Portfolio

Follow Highline Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highline Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highline Wealth Partners LLC with notifications on news.